Seeking Alpha

Alnylam Pharmaceuticals (ALNY) announces a secondary offering of approximately $125M. All of the...

Alnylam Pharmaceuticals (ALNY) announces a secondary offering of approximately $125M. All of the shares in the offering are to be sold by Alnylam. JPMorgan (JPM) and Morgan Stanley (MS) are acting as joint book-runners.
Comments (1)
  • arthurs1
    , contributor
    Comments (347) | Send Message
     
    i don't blame them, the stock is higher than it should be imo so good timing.
    14 Jan 2013, 04:27 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|